4-(2-Methyl-3-furanyl)-2-(3-methyl-1-piperidinyl)-5-(3-pyridinyl)pyrimidine 、 盐酸 以
二氯甲烷 为溶剂,
以to give the title compound as a solid (24 mg, 77%)的产率得到4-(2-methyl-3-furanyl)-2-(3-methyl-1-piperidinyl)-5-(3-pyridinyl)pyrimidine hydrochloride
参考文献:
名称:
Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer'S disease
[EN] ALPHA-7 NICOTINIC RECEPTOR MODULATORS FOR THE TREATMENT OF PAIN, A PSYCHOTIC DISORDER, COGNITIVE IMPAIRMENT OR ALZHEIMER'S DISEASE<br/>[FR] MODULATEURS DU RÉCEPTEUR ALPHA-7 NICOTINIQUE POUR LE TRAITEMENT DE LA DOULEUR, D'UN TROUBLE PSYCHOTIQUE, D'UN DÉFICIT COGNITIF OU DE LA MALADIE D'ALZHEIMER
申请人:PROXIMAGEN LTD
公开号:WO2012055942A1
公开(公告)日:2012-05-03
Compounds are disclosed which modulate the α7 nicotinic acetyl choline receptor (nAChR), having the formula (I) wherein the variables are as specified in the description and claims.
ALPHA-7 NICOTINIC RECEPTOR MODULATORS FOR THE TREATMENT OF PAIN, A PSYCHOTIC DISORDER, COGNITIVE IMPAIRMENT OR ALZHEIMER'S DISEASE
申请人:Dean David
公开号:US20130310380A1
公开(公告)日:2013-11-21
Compounds are disclosed which modulate the α7 nicotinic acetyl choline receptor (nAChR), having the formula (I) wherein the variables are as specified in the description and claims.